<p>根據 Fifth Third Bancorp 最近向證券交易委員會提交的 13F 文件，該公司在第二季度減少了對 Thermo Fisher Scientific Inc.（紐約證券交易所代碼：TMO - 免費報告）股票的持倉，減少幅度為 7.5%。該公司在此期間出售了 26,156 股後，持有 321,225 股該醫療研究公司的股票。截至最近一次向證券交易委員會提交的文件，Fifth Third Bancorp 持有的 Thermo Fisher Scientific 的股份約佔 0.09%，價值為 130,244,000 美元。</p>
<ul>
<li>現金流關注：Thermo Fisher、Energy Transfer 和網易</li>
</ul>
<p>其他一些機構投資者和對沖基金最近也對該公司的持倉進行了調整。CCM Investment Advisers LLC 在第二季度將其在 Thermo Fisher Scientific 的持股增加了 1.5%。CCM Investment Advisers LLC 現在擁有 31,344 股該醫療研究公司的股票，價值為 12,709,000 美元，此前在此期間又增持了 449 股。Sheets Smith Wealth Management 在第二季度將其在 Thermo Fisher Scientific 的持股增加了 26.8%。Sheets Smith Wealth Management 現在擁有 3,817 股該醫療研究公司的股票，價值為 1,547,000 美元，此前在此期間又增持了 807 股。Compagnie Lombard Odier SCmA 在第二季度將其在 Thermo Fisher Scientific 的持股增加了 12.2%。Compagnie Lombard Odier SCmA 現在擁有 280,728 股該醫療研究公司的股票，價值為 113,824,000 美元，此前在上個季度又增持了 30,461 股。Unified Investment Management 在第二季度將其在 Thermo Fisher Scientific 的持股增加了 16.9%。Unified Investment Management 現在擁有 968 股該醫療研究公司的股票，價值為 392,000 美元，此前在上個季度又增持了 140 股。最後，Town &amp; Country Bank &amp; Trust CO 以 First Bankers Trust CO 的名義在第二季度將其在 Thermo Fisher Scientific 的持股增加了 12.1%。Town &amp; Country Bank &amp; Trust CO 現在擁有 2,539 股該醫療研究公司的股票，價值為 1,029,000 美元，此前在上個季度又增持了 274 股。機構投資者持有該公司 89.23% 的股份。</p>
<h2>Thermo Fisher Scientific 價格表現</h2>
<p>週三，TMO 股票開盤價為 469.41 美元。Thermo Fisher Scientific Inc.的 52 周低點為 385.46 美元，52 周高點為 623.77 美元。該公司的 50 日移動平均價格為 474.01 美元，200 日移動平均價格為 448.70 美元。該公司的市值為 1772.5 億美元，市盈率為 27.15，市盈增長比率為 2.54，貝塔值為 0.75。該公司的債務與股本比率為 0.65，速動比率為 1.50，流動比率為 1.93。</p>
<ul>
<li>安捷倫科技受益於對持久性化學物質的打擊</li>
</ul>
<p>Thermo Fisher Scientific（紐約證券交易所代碼：TMO - 獲取免費報告）最近於 7 月 23 日（週三）公佈了其財報。該醫療研究公司報告本季度每股收益為 5.36 美元，超出分析師一致預期的 5.22 美元，超出幅度為 0.14 美元。Thermo Fisher Scientific 的淨利潤率為 15.24%，股本回報率為 16.82%。該公司本季度的收入為 108.6 億美元，而分析師一致預期為 106.8 億美元。去年同期，該公司每股收益為 5.37 美元。Thermo Fisher Scientific 的季度收入同比增長了 2.9%。Thermo Fisher Scientific 已將其 2025 年第三季度的每股收益指引設定為 5.460-5.510 美元。2025 財年的指引為每股收益 22.220-22.840 美元。整體來看，股票分析師預計 Thermo Fisher Scientific Inc.在當前年度的每股收益為 23.28 美元。</p>
<h2>Thermo Fisher Scientific 股息公告</h2>
<p>該公司最近還宣佈了一項季度股息，將於 10 月 15 日（週三）支付。9 月 15 日（週一）登記的投資者將獲得每股 0.43 美元的股息。這相當於每年 1.72 美元的股息，收益率為 0.4%。該股息的除息日期為 9 月 15 日（週一）。Thermo Fisher Scientific 的股息支付比率（DPR）目前為 9.95%。</p>
<h2>分析師設定新目標價</h2>
<ul>
<li>S&amp;P 500 中增長最快的四大股息：買入、賣出還是持有？</li>
</ul>
<p>幾家券商最近對 TMO 發表了評論。滙豐全球研究在 7 月 24 日（週四）的一份研究報告中將 Thermo Fisher Scientific 的股票評級從 “強力買入” 下調至 “持有”。加拿大豐業銀行在 7 月 11 日（週五）的一份研究報告中將 Thermo Fisher Scientific 的股票評級從 “行業表現” 上調至 “行業超越”，併為該公司設定了 590.00 美元的目標價。滙豐在 7 月 24 日（週四）重申了 “持有” 評級，併為 Thermo Fisher Scientific 的股票設定了 510.00 美元的目標價。瑞銀集團在 7 月 24 日（週四）將 Thermo Fisher Scientific 的股票目標價從 460.00 美元上調至 500.00 美元，並給予該公司 “中性” 評級。最後，巴克萊在 9 月 11 日（週四）將 Thermo Fisher Scientific 的股票評級從 “等權重” 上調至 “超配”，並將該公司的目標價從 490.00 美元上調至 550.00 美元。十六位投資分析師對該股票給予了買入評級，五位分析師給予了持有評級。根據 MarketBeat.com 的數據，該公司的平均評級為 “適度買入”，共識目標價為 588.35 美元。</p>
<p><strong>查看我們對 TMO 的最新分析</strong></p>
<h2>內部買賣情況</h2>
<p>在相關消息中，首席執行官 Marc N. Casper 於 8 月 22 日星期五出售了 10,000 股賽默飛世爾的股票。股票以平均價格 500.96 美元出售，總交易額為 5,009,600.00 美元。交易完成後，首席執行官持有公司 115,174 股股票，價值 57,697,567.04 美元。這筆交易代表了他們持股比例的 7.99% 的減少。該出售在向證券交易委員會的備案中披露，相關信息可在 SEC 網站上找到。此外，首席會計官 Joseph R. Holmes 於 8 月 29 日星期五出售了 385 股賽默飛世爾的股票。股票以平均價格 492.63 美元出售，總交易額為 189,662.55 美元。交易完成後，首席會計官直接持有公司 2,319 股股票，價值 1,142,408.97 美元。這代表了他們持股比例的 14.24% 的減少。該出售的披露信息可以在這裏找到。內部人士在上個季度出售了 30,066 股公司股票，價值 14,182,963 美元。內部人士持有公司 0.33% 的股票。</p>
<h2>賽默飛世爾簡介</h2>
<p>(免費報告)</p>
<p>賽默飛世爾科技公司在北美、歐洲、亞太地區及國際市場提供生命科學解決方案、分析儀器、專業診斷、實驗室產品和生物製藥服務。公司的生命科學解決方案部門提供用於生物和醫學研究、藥物和疫苗的發現與生產，以及感染和疾病的診斷的試劑、儀器和耗材；解決方案包括生物科學、遺傳科學和生物生產，服務於製藥、生物技術、農業、臨牀、醫療保健、學術和政府市場。</p>
<h2>精選文章</h2>
<ul>
<li>五隻我們認為比賽默飛世爾更好的股票</li>
<li>加拿大便士股票：它們能讓你致富嗎？</li>
<li>3 只量子計算 ETF 值得了解——而且為什麼其中 2 只不持有 D-Wave</li>
<li>這些液化天然氣股票準備迎來反彈嗎？</li>
<li>忘掉關税，Landstar 和 West Fraser 仍然可以反彈</li>
<li>澳大利亞證券交易所（ASX）是什麼</li>
<li>超級微型公司會是下一個大規模 AI 收購的對象嗎？</li>
</ul>
<p><strong>想看看其他對 TMO 感興趣的對沖基金持有哪些股票嗎？</strong> 訪問 HoldingsChannel.com，獲取賽默飛世爾科技公司（NYSE:TMO - 免費報告）的最新 13F 備案和內部交易信息。</p>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPVRNTw?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPVRNTw"/></p>
<p><em>此即時新聞提醒由敍述科學技術和 MarketBeat 的金融數據生成，以便為讀者提供最快和最準確的報道。此故事在發佈前已由 MarketBeat 的編輯團隊審核。如對該故事有任何問題或意見，請發送郵件至 contact@marketbeat.com。</em></p>
<h2>你現在應該投資 1,000 美元在賽默飛世爾嗎？</h2>
<p>在考慮投資賽默飛世爾之前，你需要聽聽這個。</p>
<p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其向客户推薦的股票。MarketBeat 已識別出五隻頂級分析師悄悄建議客户現在購買的股票，以便在更廣泛的市場注意到之前……而賽默飛世爾並不在名單上。</p>
<p>雖然賽默飛世爾目前在分析師中獲得了中等買入評級，但頂級分析師認為這五隻股票更值得購買。</p>
<p>在這裏查看這五隻股票</p>

五三銀行

賽默飛世爾

<p>五三銀行減少了在賽默飛世爾（NYSE:TMO）中的持股比例，第二季度減持了 7.5%，出售了 26,156 股，剩餘持有 321,225 股，價值約為 1.302 億美元。其他機構投資者也調整了他們的持倉。賽默飛世爾的股票開盤價為 469.41 美元，市值為 1772.5 億美元。該公司報告第二季度每股收益為 5.36 美元，超出預期，並宣佈每股季度股息為 0.43 美元，將於 10 月 15 日支付</p>

<p>Fifth Third Bancorp lessened its position in shares of Thermo Fisher Scientific Inc. (NYSE:TMO - Free Report) by 7.5% in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 321,225 shares of the medical research company's stock after selling 26,156 shares during the period. Fifth Third Bancorp owned approximately 0.09% of Thermo Fisher Scientific worth $130,244,000 as of its most recent filing with the Securities and Exchange Commission.</p>
<div class="lb-trans"><p>根據 Fifth Third Bancorp 最近向證券交易委員會提交的 13F 文件，該公司在第二季度減少了對 Thermo Fisher Scientific Inc.（紐約證券交易所代碼：TMO - 免費報告）股票的持倉，減少幅度為 7.5%。該公司在此期間出售了 26,156 股後，持有 321,225 股該醫療研究公司的股票。截至最近一次向證券交易委員會提交的文件，Fifth Third Bancorp 持有的 Thermo Fisher Scientific 的股份約佔 0.09%，價值為 130,244,000 美元。</p>
</div><ul>
<li>Cash Flow Focus: Thermo Fisher, Energy Transfer, and NetEase</li>
</ul>
<div class="lb-trans"><ul>
<li>現金流關注：Thermo Fisher、Energy Transfer 和網易</li>
</ul>
</div><p>A number of other institutional investors and hedge funds also recently made changes to their positions in the company. CCM Investment Advisers LLC lifted its holdings in shares of Thermo Fisher Scientific by 1.5% during the 2nd quarter. CCM Investment Advisers LLC now owns 31,344 shares of the medical research company's stock worth $12,709,000 after acquiring an additional 449 shares during the period. Sheets Smith Wealth Management lifted its holdings in shares of Thermo Fisher Scientific by 26.8% during the 2nd quarter. Sheets Smith Wealth Management now owns 3,817 shares of the medical research company's stock worth $1,547,000 after acquiring an additional 807 shares during the period. Compagnie Lombard Odier SCmA lifted its stake in Thermo Fisher Scientific by 12.2% in the 2nd quarter. Compagnie Lombard Odier SCmA now owns 280,728 shares of the medical research company's stock valued at $113,824,000 after purchasing an additional 30,461 shares during the last quarter. Unified Investment Management lifted its stake in Thermo Fisher Scientific by 16.9% in the 2nd quarter. Unified Investment Management now owns 968 shares of the medical research company's stock valued at $392,000 after purchasing an additional 140 shares during the last quarter. Finally, Town &amp; Country Bank &amp; Trust CO dba First Bankers Trust CO lifted its stake in Thermo Fisher Scientific by 12.1% in the 2nd quarter. Town &amp; Country Bank &amp; Trust CO dba First Bankers Trust CO now owns 2,539 shares of the medical research company's stock valued at $1,029,000 after purchasing an additional 274 shares during the last quarter. Institutional investors own 89.23% of the company's stock.</p>
<div class="lb-trans"><p>其他一些機構投資者和對沖基金最近也對該公司的持倉進行了調整。CCM Investment Advisers LLC 在第二季度將其在 Thermo Fisher Scientific 的持股增加了 1.5%。CCM Investment Advisers LLC 現在擁有 31,344 股該醫療研究公司的股票，價值為 12,709,000 美元，此前在此期間又增持了 449 股。Sheets Smith Wealth Management 在第二季度將其在 Thermo Fisher Scientific 的持股增加了 26.8%。Sheets Smith Wealth Management 現在擁有 3,817 股該醫療研究公司的股票，價值為 1,547,000 美元，此前在此期間又增持了 807 股。Compagnie Lombard Odier SCmA 在第二季度將其在 Thermo Fisher Scientific 的持股增加了 12.2%。Compagnie Lombard Odier SCmA 現在擁有 280,728 股該醫療研究公司的股票，價值為 113,824,000 美元，此前在上個季度又增持了 30,461 股。Unified Investment Management 在第二季度將其在 Thermo Fisher Scientific 的持股增加了 16.9%。Unified Investment Management 現在擁有 968 股該醫療研究公司的股票，價值為 392,000 美元，此前在上個季度又增持了 140 股。最後，Town &amp; Country Bank &amp; Trust CO 以 First Bankers Trust CO 的名義在第二季度將其在 Thermo Fisher Scientific 的持股增加了 12.1%。Town &amp; Country Bank &amp; Trust CO 現在擁有 2,539 股該醫療研究公司的股票，價值為 1,029,000 美元，此前在上個季度又增持了 274 股。機構投資者持有該公司 89.23% 的股份。</p>
</div><h2>Thermo Fisher Scientific Price Performance</h2>
<div class="lb-trans"><h2>Thermo Fisher Scientific 價格表現</h2>
</div><p>TMO stock opened at $469.41 on Wednesday. Thermo Fisher Scientific Inc. has a 52-week low of $385.46 and a 52-week high of $623.77. The company has a fifty day moving average price of $474.01 and a 200-day moving average price of $448.70. The company has a market capitalization of $177.25 billion, a P/E ratio of 27.15, a PEG ratio of 2.54 and a beta of 0.75. The company has a debt-to-equity ratio of 0.65, a quick ratio of 1.50 and a current ratio of 1.93.</p>
<div class="lb-trans"><p>週三，TMO 股票開盤價為 469.41 美元。Thermo Fisher Scientific Inc.的 52 周低點為 385.46 美元，52 周高點為 623.77 美元。該公司的 50 日移動平均價格為 474.01 美元，200 日移動平均價格為 448.70 美元。該公司的市值為 1772.5 億美元，市盈率為 27.15，市盈增長比率為 2.54，貝塔值為 0.75。該公司的債務與股本比率為 0.65，速動比率為 1.50，流動比率為 1.93。</p>
</div><ul>
<li>Agilent Technologies Thrives From the Forever Chemicals Crackdown</li>
</ul>
<div class="lb-trans"><ul>
<li>安捷倫科技受益於對持久性化學物質的打擊</li>
</ul>
</div><p>Thermo Fisher Scientific (NYSE:TMO - Get Free Report) last announced its earnings results on Wednesday, July 23rd. The medical research company reported $5.36 earnings per share for the quarter, topping analysts' consensus estimates of $5.22 by $0.14. Thermo Fisher Scientific had a net margin of 15.24% and a return on equity of 16.82%. The business had revenue of $10.86 billion during the quarter, compared to the consensus estimate of $10.68 billion. During the same quarter last year, the firm earned $5.37 earnings per share. Thermo Fisher Scientific's quarterly revenue was up 2.9% on a year-over-year basis. Thermo Fisher Scientific has set its Q3 2025 guidance at 5.460-5.510 EPS. FY 2025 guidance at 22.220-22.840 EPS. As a group, equities analysts expect that Thermo Fisher Scientific Inc. will post 23.28 EPS for the current year.</p>
<div class="lb-trans"><p>Thermo Fisher Scientific（紐約證券交易所代碼：TMO - 獲取免費報告）最近於 7 月 23 日（週三）公佈了其財報。該醫療研究公司報告本季度每股收益為 5.36 美元，超出分析師一致預期的 5.22 美元，超出幅度為 0.14 美元。Thermo Fisher Scientific 的淨利潤率為 15.24%，股本回報率為 16.82%。該公司本季度的收入為 108.6 億美元，而分析師一致預期為 106.8 億美元。去年同期，該公司每股收益為 5.37 美元。Thermo Fisher Scientific 的季度收入同比增長了 2.9%。Thermo Fisher Scientific 已將其 2025 年第三季度的每股收益指引設定為 5.460-5.510 美元。2025 財年的指引為每股收益 22.220-22.840 美元。整體來看，股票分析師預計 Thermo Fisher Scientific Inc.在當前年度的每股收益為 23.28 美元。</p>
</div><h2>Thermo Fisher Scientific Dividend Announcement</h2>
<div class="lb-trans"><h2>Thermo Fisher Scientific 股息公告</h2>
</div><p>The company also recently announced a quarterly dividend, which will be paid on Wednesday, October 15th. Investors of record on Monday, September 15th will be paid a dividend of $0.43 per share. This represents a $1.72 dividend on an annualized basis and a yield of 0.4%. The ex-dividend date of this dividend is Monday, September 15th. Thermo Fisher Scientific's dividend payout ratio (DPR) is currently 9.95%.</p>
<div class="lb-trans"><p>該公司最近還宣佈了一項季度股息，將於 10 月 15 日（週三）支付。9 月 15 日（週一）登記的投資者將獲得每股 0.43 美元的股息。這相當於每年 1.72 美元的股息，收益率為 0.4%。該股息的除息日期為 9 月 15 日（週一）。Thermo Fisher Scientific 的股息支付比率（DPR）目前為 9.95%。</p>
</div><h2>Analysts Set New Price Targets</h2>
<div class="lb-trans"><h2>分析師設定新目標價</h2>
</div><ul>
<li>Top 4 Fastest Growing S&amp;P 500 Dividends: Buy, Sell, or Hold?</li>
</ul>
<div class="lb-trans"><ul>
<li>S&amp;P 500 中增長最快的四大股息：買入、賣出還是持有？</li>
</ul>
</div><p>Several brokerages recently commented on TMO. Hsbc Global Res downgraded shares of Thermo Fisher Scientific from a &#34;strong-buy&#34; rating to a &#34;hold&#34; rating in a research note on Thursday, July 24th. Scotiabank raised shares of Thermo Fisher Scientific from a &#34;sector perform&#34; rating to a &#34;sector outperform&#34; rating and set a $590.00 price objective for the company in a research note on Friday, July 11th. HSBC reissued a &#34;hold&#34; rating and issued a $510.00 price objective on shares of Thermo Fisher Scientific in a research note on Thursday, July 24th. UBS Group raised their price target on shares of Thermo Fisher Scientific from $460.00 to $500.00 and gave the company a &#34;neutral&#34; rating in a research note on Thursday, July 24th. Finally, Barclays raised shares of Thermo Fisher Scientific from an &#34;equal weight&#34; rating to an &#34;overweight&#34; rating and raised their price target for the company from $490.00 to $550.00 in a research note on Thursday, September 11th. Sixteen investment analysts have rated the stock with a Buy rating and five have given a Hold rating to the company. Based on data from MarketBeat.com, the company has an average rating of &#34;Moderate Buy&#34; and a consensus price target of $588.35.</p>
<div class="lb-trans"><p>幾家券商最近對 TMO 發表了評論。滙豐全球研究在 7 月 24 日（週四）的一份研究報告中將 Thermo Fisher Scientific 的股票評級從 “強力買入” 下調至 “持有”。加拿大豐業銀行在 7 月 11 日（週五）的一份研究報告中將 Thermo Fisher Scientific 的股票評級從 “行業表現” 上調至 “行業超越”，併為該公司設定了 590.00 美元的目標價。滙豐在 7 月 24 日（週四）重申了 “持有” 評級，併為 Thermo Fisher Scientific 的股票設定了 510.00 美元的目標價。瑞銀集團在 7 月 24 日（週四）將 Thermo Fisher Scientific 的股票目標價從 460.00 美元上調至 500.00 美元，並給予該公司 “中性” 評級。最後，巴克萊在 9 月 11 日（週四）將 Thermo Fisher Scientific 的股票評級從 “等權重” 上調至 “超配”，並將該公司的目標價從 490.00 美元上調至 550.00 美元。十六位投資分析師對該股票給予了買入評級，五位分析師給予了持有評級。根據 MarketBeat.com 的數據，該公司的平均評級為 “適度買入”，共識目標價為 588.35 美元。</p>
</div><p><strong>Check Out Our Latest Analysis on TMO</strong></p>
<div class="lb-trans"><p><strong>查看我們對 TMO 的最新分析</strong></p>
</div><h2>Insider Buying and Selling</h2>
<div class="lb-trans"><h2>內部買賣情況</h2>
</div><p>In related news, CEO Marc N. Casper sold 10,000 shares of Thermo Fisher Scientific stock in a transaction on Friday, August 22nd. The shares were sold at an average price of $500.96, for a total transaction of $5,009,600.00. Following the completion of the transaction, the chief executive officer owned 115,174 shares of the company's stock, valued at $57,697,567.04. This trade represents a 7.99% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities &amp; Exchange Commission, which is available at the SEC website. Also, CAO Joseph R. Holmes sold 385 shares of Thermo Fisher Scientific stock in a transaction on Friday, August 29th. The stock was sold at an average price of $492.63, for a total transaction of $189,662.55. Following the transaction, the chief accounting officer directly owned 2,319 shares of the company's stock, valued at $1,142,408.97. This represents a 14.24% decrease in their position. The disclosure for this sale can be found here. Insiders sold 30,066 shares of company stock valued at $14,182,963 over the last quarter. Insiders own 0.33% of the company's stock.</p>
<div class="lb-trans"><p>在相關消息中，首席執行官 Marc N. Casper 於 8 月 22 日星期五出售了 10,000 股賽默飛世爾的股票。股票以平均價格 500.96 美元出售，總交易額為 5,009,600.00 美元。交易完成後，首席執行官持有公司 115,174 股股票，價值 57,697,567.04 美元。這筆交易代表了他們持股比例的 7.99% 的減少。該出售在向證券交易委員會的備案中披露，相關信息可在 SEC 網站上找到。此外，首席會計官 Joseph R. Holmes 於 8 月 29 日星期五出售了 385 股賽默飛世爾的股票。股票以平均價格 492.63 美元出售，總交易額為 189,662.55 美元。交易完成後，首席會計官直接持有公司 2,319 股股票，價值 1,142,408.97 美元。這代表了他們持股比例的 14.24% 的減少。該出售的披露信息可以在這裏找到。內部人士在上個季度出售了 30,066 股公司股票，價值 14,182,963 美元。內部人士持有公司 0.33% 的股票。</p>
</div><h2>Thermo Fisher Scientific Profile</h2>
<div class="lb-trans"><h2>賽默飛世爾簡介</h2>
</div><p>(Free Report)</p>
<div class="lb-trans"><p>(免費報告)</p>
</div><p>Thermo Fisher Scientific Inc provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases; and solutions include biosciences, genetic sciences, and bio production to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets.</p>
<div class="lb-trans"><p>賽默飛世爾科技公司在北美、歐洲、亞太地區及國際市場提供生命科學解決方案、分析儀器、專業診斷、實驗室產品和生物製藥服務。公司的生命科學解決方案部門提供用於生物和醫學研究、藥物和疫苗的發現與生產，以及感染和疾病的診斷的試劑、儀器和耗材；解決方案包括生物科學、遺傳科學和生物生產，服務於製藥、生物技術、農業、臨牀、醫療保健、學術和政府市場。</p>
</div><h2>Featured Articles</h2>
<div class="lb-trans"><h2>精選文章</h2>
</div><ul>
<li>Five stocks we like better than Thermo Fisher Scientific</li>
<li>Canadian Penny Stocks: Can They Make You Rich?</li>
<li>3 Quantum Computing ETFs to Know—And Why 2 Don't Hold D-Wave</li>
<li>Are These Liquid Natural Gas Stocks Ready For An Upside Bounce?</li>
<li>Forget Tariffs, Landstar and West Fraser Can Still Rally</li>
<li>What is the Australian Securities Exchange (ASX)</li>
<li>Is Super Micro Next in Line for a Big AI Takeover?</li>
</ul>
<div class="lb-trans"><ul>
<li>五隻我們認為比賽默飛世爾更好的股票</li>
<li>加拿大便士股票：它們能讓你致富嗎？</li>
<li>3 只量子計算 ETF 值得了解——而且為什麼其中 2 只不持有 D-Wave</li>
<li>這些液化天然氣股票準備迎來反彈嗎？</li>
<li>忘掉關税，Landstar 和 West Fraser 仍然可以反彈</li>
<li>澳大利亞證券交易所（ASX）是什麼</li>
<li>超級微型公司會是下一個大規模 AI 收購的對象嗎？</li>
</ul>
</div><p><strong>Want to see what other hedge funds are holding TMO?</strong> Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Thermo Fisher Scientific Inc. (NYSE:TMO - Free Report).</p>
<div class="lb-trans"><p><strong>想看看其他對 TMO 感興趣的對沖基金持有哪些股票嗎？</strong> 訪問 HoldingsChannel.com，獲取賽默飛世爾科技公司（NYSE:TMO - 免費報告）的最新 13F 備案和內部交易信息。</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPVRNTw" alt="" original-src="https://www.marketbeat.com/scripts/SECFilingChart.ashx?Prefix=NYSE&amp;Symbol=TMO"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即時新聞提醒由敍述科學技術和 MarketBeat 的金融數據生成，以便為讀者提供最快和最準確的報道。此故事在發佈前已由 MarketBeat 的編輯團隊審核。如對該故事有任何問題或意見，請發送郵件至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in Thermo Fisher Scientific Right Now?</h2>
<div class="lb-trans"><h2>你現在應該投資 1,000 美元在賽默飛世爾嗎？</h2>
</div><p>Before you consider Thermo Fisher Scientific, you'll want to hear this.</p>
<div class="lb-trans"><p>在考慮投資賽默飛世爾之前，你需要聽聽這個。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Thermo Fisher Scientific wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其向客户推薦的股票。MarketBeat 已識別出五隻頂級分析師悄悄建議客户現在購買的股票，以便在更廣泛的市場注意到之前……而賽默飛世爾並不在名單上。</p>
</div><p>While Thermo Fisher Scientific currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>雖然賽默飛世爾目前在分析師中獲得了中等買入評級，但頂級分析師認為這五隻股票更值得購買。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在這裏查看這五隻股票</p>
</div>

五三銀行出售了賽默飛世爾科技公司 26,156 股股票 $TMO